3rd Quarter - Report

TIBER CREEK GROUP for BRISTOL MYERS SQUIBB

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169).

LobbyistCovered position, as disclosed
COREY MALMGREN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA.

LobbyistCovered position, as disclosed
COREY MALMGREN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.